drugset / Trial / NCT02229747
Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study was to assess the clinical efficacy and safety of meloxicam suspension 0.25 mg/kg/day once a day, versus diclofenac suspension 1 mg/kg/day twice a day or nimesulide suspension 4 mg/kg/day twice a day, after five days of treatment in patients with a diagnosis of acute, non-bacterial pharyngitis, pharyngotonsillitis or laryngitis
Timeline
- Start
- 2001-08
- Primary completion
- 2002-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diclofenac | Other / unclassified | 1 mg/kg | — |
| Subject | Meloxicam | Small molecule | 0.25 mg/kg | — |
| Comparator | Nimesulide | Small molecule | 4 mg/kg | — |